Psychedelic Nasal Spray Shows Promise Against Depression

As psilocybin industry launches in Colorado, hope and worry collide

On the surface, Colorado's budding psychedelic industry had several causes for celebration in the last few weeks: Gov. Jared Polis announced mass pardons for psilocybin convictions and the state saw its first patient take a dose of "magic mushroom" —…

Local advocate talks about growing support for psychedelic treatments

FARGO, N.D. (KVRR) — With more and more data showing the efficacy of psychedelic treatments for PTSD and other mental health conditions, there has been growing support for their availability. Studies like one at Emery University have shown that psychedelics such as psilocybin could be effective for patients with treatment-resistant depression, and in Minnesota, the Psychedelic Drug Task Force recommended that psilocybin be decriminalized in a bi…

Psychedelic compound blurs boundary between self and others in the brain, study finds

A new study has found that a psychedelic formulation inspired by ayahuasca can significantly alter how the brain processes faces—especially one’s own. The research shows that the compound changes both early visual perception and later self-referential processing, effectively weakening the brain’s usual distinction between self and others. These findings, published in the journal NeuroImage, could help explain why psychedelics often produce feeli…

Beckley psychedelic hits the target, unlocking atai merger

The proposed merger between Beckley Psytech and atai is unlocked as a psychedelic for depression hits all its endpoints in a phase 2b trial.

Atai and Beckley, set to merge, reveal study success for psychedelic drug

Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray into pivotal testing.